Speckle-type POZ protein mutations in prostate cancer: a new part of the mosaic
Main Author: | Robert Stoehr |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-02-01
|
Series: | Asian Journal of Andrology |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=1;spage=161;epage=161;aulast=Stoehr |
Similar Items
-
Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
by: John Lai, et al.
Published: (2014-10-01) -
Identification of speckle-type POZ protein somatic mutations in African American prostate cancer
by: Eric Buckles, et al.
Published: (2014-12-01) -
ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance
by: Cheol-Jung Lee, et al.
Published: (2024-04-01) -
The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1
by: Chunli Wei, et al.
Published: (2022-09-01) -
Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
by: Yan He, et al.
Published: (2021-11-01)